Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 12, 2022

SELL
$57.92 - $72.58 $57 - $72
-1 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$64.88 - $73.64 $64 - $73
1 New
1 $0
Q3 2021

Oct 05, 2021

SELL
$67.69 - $73.03 $6,362 - $6,864
-94 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$56.65 - $64.55 $396 - $451
-7 Reduced 6.93%
94 $5,000
Q2 2020

Jul 28, 2020

SELL
$72.34 - $84.0 $10,416 - $12,096
-144 Reduced 58.78%
101 $8,000
Q1 2020

Apr 22, 2020

SELL
$62.63 - $80.22 $6,012 - $7,701
-96 Reduced 28.15%
245 $18,000
Q4 2019

Jan 22, 2020

BUY
$61.62 - $67.78 $21,012 - $23,112
341 New
341 $22,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Savior LLC Portfolio

Follow Savior LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savior LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savior LLC with notifications on news.